These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22011696)

  • 1. Individual differences in prothrombin time-international normalized ratio variation following coadministration of the anticancer agents S-1 and warfarin: 3 case reports.
    Yamamuro F; Miki A; Kondo G; Maeda T; Satoh H; Hori S; Sawada Y
    Int J Clin Pharmacol Ther; 2011 Nov; 49(11):700-4. PubMed ID: 22011696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of capecitabine and S-1 on anticoagulant activity of warfarin in patients with gastrointestinal cancer.
    Hata T; Kudo T; Sakai D; Takahashi H; Haraguchi N; Nishimura J; Hata T; Mizushima T; Yamamoto H; Doki Y; Mori M; Satoh T
    Cancer Chemother Pharmacol; 2016 Aug; 78(2):389-96. PubMed ID: 27339150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Invention of a tumor-selective 5-fluorouracil derivative named S-1 by biochemical modulation of 5-fluorouracil].
    Shirasaka T; Shimamoto Y; Kato T; Fukushima M
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):371-84. PubMed ID: 9492831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of 5-fluorouracil (5-FU) gastrointestinal (GI) toxicity resulting from the protection of thymidylate synthase (TS) in GI tissue by repeated simultaneous administration of potassium oxonate (Oxo) in rats.
    Yoshisue K; Hironaga K; Yamaguchi S; Yamamoto A; Nagayama S; Kawaguchi Y
    Cancer Chemother Pharmacol; 2000; 46(1):51-6. PubMed ID: 10912578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Successful Case of a Patient Undergoing Warfarin and S-1 Therapy Using Internet-based Control of Home-measured PT-INR.
    Yamamura K; Yano K; Hirooka Y; Hirashiki A; Murohara T; Yamada K
    Yakugaku Zasshi; 2015; 135(7):925-7. PubMed ID: 25913669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of Tramadol Coadministration on Prothrombin Time-International Normalized Ratio in Patients Receiving Warfarin].
    Hosono T; Kondo A; Kambayashi Y; Homma M
    Yakugaku Zasshi; 2017; 137(8):999-1003. PubMed ID: 28768953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the anticoagulant effect and timing of the concomitant use of S-1 and warfarin.
    Suzuki S; Ikegawa K; Yamamoto K; Saito S
    J Int Med Res; 2016 Oct; 44(5):1123-1130. PubMed ID: 27553806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of Drug Interaction between S-1 and Warfarin].
    Yamamoto K; Suzuki S; Ikegawa K; Nomura H; Fuse N; Saito S
    Gan To Kagaku Ryoho; 2016 Jan; 43(1):65-8. PubMed ID: 26809527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug interaction between capecitabine and warfarin: a case report and review of the literature.
    Yildirim Y; Ozyilkan O; Akcali Z; Basturk B
    Int J Clin Pharmacol Ther; 2006 Feb; 44(2):80-2. PubMed ID: 16502767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible regulation of 5-fluorouracil-induced neuro- and oral toxicities by two biochemical modulators consisting of S-1, a new oral formulation of 5-fluorouracil.
    Kato T; Shimamoto Y; Uchida J; Ohshimo H; Abe M; Shirasaka T; Fukushima M
    Anticancer Res; 2001; 21(3B):1705-12. PubMed ID: 11497250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reinforcement of warfarin action in a patient administered S-1].
    Watanabe H; Itoh H; Tsuchiya Y; Miyagi N; Sugiyama T; Nakai Y; Shinozaki Y; Noguchi T; Jinbu Y; Kusama M
    Gan To Kagaku Ryoho; 2015 Jan; 42(1):131-3. PubMed ID: 25596696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Timeline from discovery of 5-FU to development of an oral anticancer agent S-1 and its drug concept].
    Shirasaka T; Taguchi T
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():4-18. PubMed ID: 16897967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple doses of sitagliptin, a selective DPP-4 inhibitor, do not meaningfully alter pharmacokinetics and pharmacodynamics of warfarin.
    Wright DH; Herman GA; Maes A; Liu Q; Johnson-Levonas AO; Wagner JA
    J Clin Pharmacol; 2009 Oct; 49(10):1157-67. PubMed ID: 19783710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of azole antifungal agents on the anticoagulant activity of warfarin.
    Yamamoto H; Habu Y; Yano I; Ozaki J; Kimura Y; Sato E; Shida A; Fukatsu S; Matsubara K
    Biol Pharm Bull; 2014; 37(12):1990-3. PubMed ID: 25451849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations of prothrombin time and international normalized ratio in patients treated with warfarin.
    Ho CH; Lin MW; You JY; Chen CC; Yu TJ
    Thromb Res; 2002 Sep; 107(5):277-80. PubMed ID: 12479890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the 5-fluorouracil-warfarin and capecitabine-warfarin drug interactions.
    Shah SR; Martin R; Dowell JE; Ussery SM
    Pharmacotherapy; 2010 Dec; 30(12):1259-65. PubMed ID: 21128758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moxifloxacin-warfarin interaction: a series of five case reports.
    Elbe DH; Chang SW
    Ann Pharmacother; 2005 Feb; 39(2):361-4. PubMed ID: 15632222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-Dimer versus International Normalized Ratio of Prothrombin Time in Ischemic Stroke Patients Treated with Sufficient Warfarin.
    Yamamoto R; Nakae Y; Tanaka F; Johkura K
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1781-1785. PubMed ID: 27103270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer.
    Camidge R; Reigner B; Cassidy J; Grange S; Abt M; Weidekamm E; Jodrell D
    J Clin Oncol; 2005 Jul; 23(21):4719-25. PubMed ID: 16034047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.